- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Is IBB the Best Biotech ETF?
-
Biotech ETFs: A Better Way to Go
-
Exploring Biotech ETFs
-
11 Months After the Oil Bubble Burst
-
How Biotech ETFs Can Rise Above Challenges
-
Time to Increase Investment in Healthcare?
-
Screening for Trends
-
Bob Doll Favors Energy, Tech and Health Services
-
That Was Not a 2:1 Split in BBH
-
How Biotech ETFs Are Overcoming Sector’s Troubles
-
Big Mergers Could Mean Sweet Gains for Biotech
-
In Search of Value Stocks? Try Beverages and Healthcare
-
Natalie Pace: Investors Should Worry About Being Safe and Properly Diversifying
-
How Obama's Healthcare Reform Could Affect Biotech ETFs
-
Watch This Sector During the Upcoming Bear Market Rally
-
What the Stimulus Plan Means for ETFs, Sector by Sector
-
The Media Are Over-Hyping Recent Market Gains
-
Biotechs: The Cash Crunch
-
Tough Love for Biotech Industry
-
Utilities and Biotech ETFs: Shining Stars During Terrible Trading Days
-
How Is the Biotech Industry Holding Up?
-
Taking Advantage of Biotech Sector with ETFs
-
Is It Time to Buy? What History Shows
-
Winning and Losing Sectors for the Obama Administration
-
Healthcare ETFs Are Outpacing the Market
-
Recessionary Equity Strategies: Choosing Defensive Businesses
-
'When There's Blood in the Streets', Buy Biotech Stocks
-
Biotech ETFs: Can You Handle 209% Volatility?
-
Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
-
ETFs In Greatest Demand: Financials, Healthcare/Biotech; India's Signs of Life
-
Most Overbought and Oversold ETFs
-
A Biotech Bloom in July
-
Biotech Buying Binge About to Begin?
-
Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
-
Portfolio Review: Biotech, Utilities Help Maintain Defensive Posture
-
ETF Update: Utilities, Retail, Biotech and Agriculture
-
Key ETFs Most Overbought and Oversold
-
Biotech Fundamentals Still Look Strong
-
ETF Update: HOLDRs, Leveraged ETFs,
-
Biotech ETFs: Volatility, Technicals Pointing to a Recovery?
-
Time for Biotech To Turn Around?